Anti-inflammatory, Antiarthritic and Antinociceptive Activities of 3,5-Disubstituted Thiazolidine Derivatives

References (40)

1. 1 An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ) [DOI]
2. 2 15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ [DOI]
3. 3 Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis [DOI]
4. 4 ACETIC ACID FOR ANALGESIC SCREENING
5. 5 Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ [DOI]
6. 6 The PPARs: From Orphan Receptors to Drug Discovery [DOI]
7. 7 Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. [DOI]
8. 8 The PPARα–leukotriene B4 pathway to inflammation control [DOI]
9. 9 Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse [DOI]
10. 10 Peroxisome Proliferator-activated Receptors α and γ Are Activated by Indomethacin and Other Non-steroidal Anti-inflammatory Drugs [DOI]
11. 11 Development of Arthritis, Periarthritis and Periostitis in Rats Given Adjuvants. [DOI]
12. 12 Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor [DOI]
13. 13 Release of prostaglandins E and F in an algogenic reaction and its inhibition [DOI]
14. 14 Involvement of resident macrophages and mast cells in the writhing nociceptive response induced by zymosan and acetic acid in mice [DOI]
15. 15 CHEMOTHERAPY OF ARTHRITIS INDUCED IN RATS BY MYCOBACTERIAL ADJUVANT [DOI]
16. 16 Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro [DOI]
17. 17 Mechanisms of Disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis [DOI]
18. 18 State-of-the-art: rheumatoid arthritis [DOI]
19. 19 Duration of preclinical rheumatoid arthritis-related autoantibody positivity increases in subjects with older age at time of disease diagnosis [DOI]
20. 20 Physical activity and health related quality of life among people with arthritis [DOI]
21. 21 15-deoxy-Δ12,14-PGJ2 induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats [DOI]
22. 22 Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices: II. Second line drugs and prednisone.
23. 23 RETRACTED: Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-γ, reduces acute inflammation [DOI]
24. 24 Synthesis and anti-inflammatory activity of new arylidene-thiazolidine-2,4-diones as PPARγ ligands [DOI]
25. 25 Clinical aspects of rheumatoid arthritis [DOI]
26. 26 Reduction in the evolution of murine type II collagen–induced arthritis by treatment with rosiglitazone, a ligand of the peroxisome proliferator–activated receptor γ [DOI]
27. 27 Signalling platforms that modulate the inflammatory response: new targets for drug development [DOI]
28. 28 Antinociceptive and antiedematogenic activities of fenofibrate, an agonist of PPAR alpha, and pioglitazone, an agonist of PPAR gamma [DOI]
29. 29 Painful Rheumatoid Arthritis [DOI]
30. 30 Further Antinociceptive Properties of Extracts and Phenolic Compounds from Plinia glomerata (Myrtaceae) Leaves [DOI]
31. 31 Anti-inflammatory and anti-arthritic activities of 3,4-dihydro-2,2-dimethyl-2H-naphthol[1,2-b]pyran-5,6-dione (β-lapachone) [DOI]
32. 32 Association of interleukin‐18 expression with enhanced levels of both interleukin‐1β and tumor necrosis factor α in knee synovial tissue of patients with rheumatoid arthritis [DOI]
33. 33 Studies of eicosanoid production in the air pouch model of synovial inflammation [DOI]
34. 34 Selective Modulators of PPAR Activity as New Therapeutic Tools in Metabolic Diseases [DOI]
35. 35 An Overview of Economic Evaluations for Drugs Used in Rheumatoid Arthritis [DOI]
36. 36 Peroxisome Proliferator-Activated Receptor Agonists Inhibit Inflammatory Edema and Hyperalgesia [DOI]
37. 37 Peroxisome Proliferator Activated Receptor Ligands as Regulators of Airway Inflammation and Remodelling in Chronic Lung Disease [DOI]
38. 38 Adjuvant arthritis 50 years on: the impact of the 1956 article by C. M. Pearson, ‘Development of arthritis, periarthritis and periostitis in rats given adjuvants’ [DOI]
39. 39 Preclinical pharmacokinetic and pharmacodynamic evaluation of thiazolidinone PG15: an anti-inflammatory candidate [DOI]
40. 40 The analgesic action of baclofen [beta-(4-chlorophenyl)-gamma-aminobutyric acid]. [DOI]

Cited by 3

Showing 1 of 3 known citations — external sources report more than can currently be individually listed.

Related research

• Evaluation of Plasma Levels of Interleukin 6 and Iron of Volleyball Players Based on Heights and Weight of a Nigerian University Students — shares topic coverage
• The Use of Complete Blood Count as Inflammatory Biomarkers in Patients with Colorectal Cancers in Enugu State University of Science and Technology Teaching Hospital, Parklane Enugu — shares topic coverage
• Integrating Network Pharmacology and Traditional Chinese Medicine for Effective Inflammation Treatment — shares topic coverage
• Preliminary Phytochemical Screening and Physiochemical Studies of Eucalyptus camaldulensis and Ocimum tenuiflorum — shares topic coverage
• Ebselen a Seleno-organic Molecule Inhibits Alteration in the Biological Responses in Hypoxic Human Alveolar Lung Epithelial Cells — shares topic coverage